What is NDC 66993-189?

66993-189 is the product NDC for Umeclidinium Ellipta (umeclidinium), Umeclidinium bromide 62.5 ug/1 aerosol, powder, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Umeclidinium Ellipta (Umeclidinium).

Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Umeclidinium Ellipta?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Umeclidinium Ellipta NDC 66993-189

NDC codes

FDA NDC Directory

Product NDC (as listed)66993-189Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66993-0189Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66993-189-97	6699301899766993018997	1 TRAY in 1 CARTON (66993-189-97) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALERMarketed from Apr 6, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Umeclidinium Ellipta
Generic name (nonproprietary): umeclidinium
Active ingredients: Umeclidinium bromide — 62.5 ug/1
Dosage form: Aerosol, Powder
Route: Oral
Labeler: Prasco LaboratoriesNDC labeler code 66993
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 205382
Marketing start: Apr 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 66993-189_78029af6-3c01-4be0-8439-ec3c22b4abb7SPL ID 78029af6-3c01-4be0-8439-ec3c22b4abb7SPL set ID 763388a5-cc89-4c25-8562-521df679b7e8RxCUI 1539251UNII 7AN603V4JV
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466993018997 followed by a unit qualifier and the quantity

Package 66993-0189-97. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 6, 2025.

Indications (excerpt from the label)

Umeclidinium ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Umeclidinium ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66993-189

What is NDC 66993-189?: 66993-189 is the product NDC for Umeclidinium Ellipta (umeclidinium), Umeclidinium bromide 62.5 ug/1 aerosol, powder, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Umeclidinium Ellipta (Umeclidinium).
What is the active ingredient?: Umeclidinium bromide.
Who is the labeler?: Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Umeclidinium Ellipta?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 205382

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 205382
Product	Strength	Form · route	Labeler	Product NDC
Incruse Elliptaumeclidinium	Umeclidinium bromide 62.5 ug/1	Aerosol, PowderOral	GlaxoSmithKline LLC	0173-0873

Umeclidinium Ellipta (Umeclidinium) NDC 66993-189